Back to Trades
Total Value
$0
Filing Date
Jul 24, 2026
1 transactions
Trade Summary
On Jul 22, 2026, Oulman Roxanne, Director, reported $0 of Klaviyo, Inc. (KVYO) across 1 transactions. The filing covers Series A Common Stock and reflects balanced net activity of $0. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Klaviyo, Inc.
- Ticker Symbol
- KVYO
- CIK
- 0001835830
Insider Information
- Name
- Oulman Roxanne
- Role
- Director
- Location
- BOSTON, MA
Filing Details
- Filing Date
- Jul 24, 2026
- Transaction Date
- Jul 22, 2026
- Accession Number
- 0001470831-26-000729
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jul 22, 2026 | Series A Common Stock | 16,775 | — | C | — |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jul 22, 2026 | KVYO derivative | 16,775 | — | C | — |
Want live alerts when Oulman Roxanne trades again?
Download Insider Trades to track KVYO, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date.
- (F2)Shares held by Roxanne Oulman 2025 GRAT, of which the Reporting Person serves as trustee. The Reporting Person disclaims Section 16 beneficial ownership of such shares except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed to be an admission that she has beneficial ownership of such shares for Section 16 or any other purpose.
- (F3)Consists of (i) 22,521 shares of Series A Common Stock and (ii) 14,822 unvested restricted stock units awarded under the Issuer's 2023 Stock Option and Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement.